Menopause Specialist in NYC: What the Title Actually Means

The Title

What a Menopause Specialist in NYC Actually Is

A menopause specialist in NYC is a self-description. It is not a license, and it is not a board certification. New York does not license anyone to practice menopause: the State Education Department's Office of the Professions lists Medicine among the state's licensed professions, with physicians, physician assistants and specialist assistants under it, and there is no menopause line on that list.

The nearest thing to a credential is the Menopause Society Certified Practitioner designation, written MSCP. It is a voluntary competency credential rather than a specialty board, and The Menopause Society publishes an opt-in directory of members and MSCPs. The directory's own terms state that the Society does not endorse or recommend the practitioners included in it, and the directory separately notes that members and MSCPs who are not accepting new patients are not listed. It is a starting list, not a ranking.

The clinicians doing this work in New York are gynecologists, internists, family physicians and nurse practitioners who took the subject seriously, some of whom hold the MSCP. The useful question is not what a practice calls itself, but whether the person writing your prescription is licensed where you are sitting.

How to Check One

How to Check a New York Menopause Prescriber in Two Minutes

Checking a New York menopause prescriber takes two public look-ups and no phone call. New York is unusual here: physicians are licensed by the State Education Department rather than a standalone medical board, and the register is open to anyone.

• Confirm the license. The New York State Education Department runs a public verification search covering its licensed professions, Medicine among them. Search the clinician by name and confirm the license is current.
• Check the MSCP claim, if one is made. The Menopause Society's directory of members and certified practitioners has a filter for clinicians seeing patients by telehealth in a given state. A practice advertising the credential should appear in it.
• Ask who signs the prescription. A clinic is not a prescriber. The name on the prescription has to hold the New York license, and it is not always the name on the website.

A practice can be excellent without the MSCP. What it should not do is imply a certification it does not hold.

The New York Rules

Estradiol and Progesterone Are Not Controlled Substances. Testosterone Is.

Estradiol and progesterone appear on no federal controlled-substance schedule, and that one fact sets the telehealth rules for menopause care in New York. Neither hormone appears in the DEA's alphabetical list of controlled substances; testosterone does, in schedule III. The in-person requirement New York has applied to controlled substances since May 21, 2025 under 10 NYCRR 80.63(d)(1) does not reach them, and neither does the temporary federal telemedicine flexibility that testosterone prescribing still rests on.

The binding question is a licensing one, and your address answers it rather than the clinic's. A clinician needs authority to treat a patient physically located in New York, and that authority is statewide: a visit held from a kitchen in Riverdale and one held from a kitchen in Rochester fall under the same license. Proximity buys nothing. A waiting room ten blocks away can belong to someone who cannot lawfully write for you, and a practice you will never set foot in can belong to someone who can.

Testosterone is the exception inside women's hormone care, and it is worth knowing before a clinic offers it. Testosterone is a Schedule III controlled substance under federal law and is listed by name among the anabolic steroids in New York Public Health Law §3306 state Schedule II, and the New York State Department of Health states that, effective August 27, 2013, most prescribers must consult the Prescription Monitoring Program registry when writing for Schedule II, III and IV drugs. A testosterone prescription in New York carries a registry check that an estradiol prescription does not.

E-Prescribing

Why Your New York Hormone Prescription Arrives Electronically

Your New York hormone prescription is transmitted electronically because the state requires it. The New York State Department of Health states that practitioners are mandated to electronically prescribe both controlled and non-controlled substances, effective March 27, 2016, with a defined set of exceptions under which a paper, oral or faxed prescription may still be issued.

Most states wrote that rule for opioids alone. New York wrote it for everything, which is why an estradiol patch and a progesterone capsule sit inside it, and why nobody hands you a paper script at the end of a telehealth visit.

The consequence is practical. Your prescriber needs your pharmacy before the visit ends, because the prescription goes straight there, and a clinic that cannot e-prescribe into New York has not set itself up to treat you here.

The 2026 Labels

The Boxed Warning Changed in 2026, and Timing Still Decides the Rest

The warning on menopausal hormone therapy labels changed across two dates, and both matter. On November 10, 2025 the FDA announced it was initiating removal of the boxed-warning references to cardiovascular disease, breast cancer and probable dementia, while stating that it is not seeking to remove the boxed warning for endometrial cancer on systemic estrogen-alone products. On February 12, 2026 it approved the first six revised labels. The endometrial cancer boxed warning on systemic estrogen-alone products stays. Twenty-nine drug companies have submitted proposed labeling changes, so that first batch is not the last of it.

A removed warning is not a clearance. It is the removal of a blanket, and an individual calculation sits underneath it. In that February announcement the FDA noted that randomized studies show women who begin hormone therapy within 10 years of the onset of menopause, generally before age 60, have a reduction in all-cause mortality and fractures. The 2022 hormone therapy position statement of The North American Menopause Society draws the same line on timing: for women under 60 or within 10 years of menopause onset and without contraindications the benefit-risk ratio is favorable, and for women who start more than 10 years out it appears less favorable. Age, years since your final period, your history and the route of delivery all move that calculation, which is why it belongs to a prescriber who has read your records.

What the FDA label change does and does not say has a page of its own. And if the stage itself is unsettled, perimenopause versus menopause is the earlier question, because the two are managed differently.

Six Questions

Six Questions for a Menopause Clinic in NYC, Long Island or Upstate

Six questions separate a menopause practice from a storefront. Each has a one-sentence answer, and a good clinic gives all six without hesitating.

• Who signs the prescription, and can I find them on the state register? The signer is the one who needs the license, and the register settles it in under a minute.
• Do you hold the MSCP credential, or are you describing an interest? Both answers are acceptable. Only one of them is a certification.
• Which hormones, by which route? A patch, a gel and a capsule behave differently, and the choice should carry a reason.
• FDA-approved products or compounded preparations? Compounded hormone preparations are not FDA-approved, and a clinic should say which it uses without being pressed.
• What is reassessed, and when? Hormone therapy is revisited, not subscribed to.
• What happens if you decide not to treat me? A package paid for up front should not quietly outlive a clinical no.

A clinic worth your time answers all six without checking with anyone, and the answers should be identical whether you are sitting in Murray Hill, Massapequa or Saratoga Springs. Westchester patients have a fuller page of their own on hormone replacement therapy for women in Westchester.

Our Approach

Menopause Care at Protocol Health: New York by Video, Scarsdale in Person

Protocol Health is a physician-led longevity practice in Scarsdale, New York. It treats New York patients by video across the state and in person at the Scarsdale clinic, and by telehealth in New Jersey, Connecticut, Florida and California. There is no Protocol Health office in Manhattan, Brooklyn, Queens, the Bronx, Staten Island or on Long Island.

Protocol Health sells hormone replacement therapy for women, so read this page as written by an interested party. That interest is exactly why it leans on the state register, the Department of Health's own rules and the FDA's own announcements instead of on adjectives. Three points of regulatory status, stated plainly:

• FDA-approved estradiol and micronized progesterone products are approved drugs, prescribed for the indications on their labels and, where a clinician judges it appropriate, outside them.
• Compounded hormone preparations are not FDA-approved. A pharmacy makes them to a prescription, and they are not reviewed for safety, efficacy or manufacturing quality the way an approved product is.
• No testosterone product is FDA-approved for women in the United States, so any testosterone prescribed to a woman is off-label and an individual decision made with the prescriber.

To answer this page's own second question: Protocol Health makes no Menopause Society Certified Practitioner claim, here or anywhere else on this site, which is the reason it tells you to check a credential rather than take a clinic's word for one. The treating clinician decides whether hormone therapy is appropriate for you, in which form and at what dose, against your history and your labs. This page sets no dose and gives no individual advice. Start with the two-minute health quiz if you want a clinician to look at your situation.

FAQ

Frequently Asked Questions

Explore

Related at Protocol Health

• HRT for Women →
• HRT for Women in Westchester →
• Menopause Hormone Therapy →
• Perimenopause vs Menopause →